News + Publications

What’s new at Dispatch

Explore what’s next as we work to expand the curative potential of immunotherapies for solid tumors.

Dispatch Bio Unveils First Clinical Program and Presents Data Supporting Flare Platform at Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting

Tue Nov 04 2025

Dispatch Bio Announces Clinical Supply and Collaboration Agreement with Bristol Myers Squibb in Solid Tumors

Tue Nov 04 2025

Dispatch Bio Announces Upcoming Presentations at Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting

Fri Oct 03 2025

Dispatch Bio Appoints Mauro Avanzi, M.D., Ph.D., as Chief Medical Officer

Tue Sep 30 2025

Dispatch Bio named to 2025 Endpoints 11 List

Fri Sep 19 2025 | Endpoints

Dispatch Bio Launches to Deliver Universal Treatment Across Solid Tumors with Novel Immunotherapy Approach

Wed Jul 23 2025